{
  "id": 998036,
  "name": "Total confirmed gonorrhea infections tested for antibiotic susceptibility",
  "unit": "infections",
  "createdAt": "2024-11-19T12:34:18.000Z",
  "updatedAt": "2025-02-12T17:22:41.000Z",
  "coverage": "",
  "timespan": "2016-2022",
  "datasetId": 6807,
  "columnOrder": 0,
  "shortName": "total_bcis_with_ast_gonorrhea",
  "catalogPath": "grapher/antibiotics/2024-11-15/testing_coverage/testing_coverage#total_bcis_with_ast_gonorrhea",
  "descriptionShort": "Total bacteriologically confirmed gonorrhea infections tested for antibiotic susceptibility.",
  "type": "int",
  "dataChecksum": "15434276890534048460",
  "metadataChecksum": "1583489633445779438",
  "datasetName": "Global Antimicrobial Resistance and Use Surveillance System (GLASS) - Testing Coverage",
  "updatePeriodDays": 365,
  "datasetVersion": "2024-11-15",
  "nonRedistributable": false,
  "display": {
    "name": "Gonorrhea infections",
    "unit": "infections"
  },
  "schemaVersion": 2,
  "presentation": {
    "topicTagsLinks": [
      "Antibiotics & Antibiotic Resistance"
    ]
  },
  "descriptionKey": [
    "Neisseria gonorrhoeae infections are tested for their susceptibility to macrolide antibiotics and third-generation cephalosporin antibiotics."
  ],
  "dimensions": {
    "years": {
      "values": [
        {
          "id": 2016
        },
        {
          "id": 2017
        },
        {
          "id": 2018
        },
        {
          "id": 2019
        },
        {
          "id": 2020
        },
        {
          "id": 2021
        },
        {
          "id": 2022
        }
      ]
    },
    "entities": {
      "values": [
        {
          "id": 277958,
          "name": "African Region (WHO)",
          "code": null
        },
        {
          "id": 355,
          "name": "World",
          "code": "OWID_WRL"
        },
        {
          "id": 369119,
          "name": "Eastern Mediterranean (WHO)",
          "code": null
        },
        {
          "id": 277955,
          "name": "European Region (WHO)",
          "code": null
        },
        {
          "id": 277957,
          "name": "Region of the Americas (WHO)",
          "code": null
        },
        {
          "id": 277953,
          "name": "South-East Asia Region (WHO)",
          "code": null
        },
        {
          "id": 277952,
          "name": "Western Pacific Region (WHO)",
          "code": null
        }
      ]
    }
  },
  "origins": [
    {
      "id": 2045,
      "title": "Global Antimicrobial Resistance and Use Surveillance System (GLASS) - Testing Coverage",
      "description": "GLASS provides a standardized approach to the collection, analysis, interpretation and sharing of data by countries and seeks to actively support capacity building and monitor the status of existing and new national surveillance systems. Furthermore, GLASS promotes a shift from surveillance approaches based solely on laboratory data to a system that includes epidemiological, clinical, and population-level data. GLASS has been conceived to progressively incorporate data from surveillance of AMR in humans, such as monitoring of resistance and the use of antimicrobial medicines, including AMR in the food chain and in the environment.",
      "producer": "World Health Organization",
      "citationFull": "Global AMR data - Global Antimicrobial Resistance and Use Surveillance System (GLASS), World Health Organization (2024)",
      "attributionShort": "WHO",
      "urlMain": "https://worldhealthorg.shinyapps.io/glass-dashboard/_w_679389fb/#!/amr",
      "dateAccessed": "2024-11-15",
      "datePublished": "2024-09-16",
      "license": {
        "url": "https://www.who.int/about/policies/terms-of-use",
        "name": "Â© 2024 WHO"
      }
    }
  ]
}